Worldwide Clot Buster Drugs Industry to 2027 - by Type, Application, Distribution Channel and Region - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--Sep 26, 2022--

The "Clot Buster Drugs Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2017-2027" report has been added to ResearchAndMarkets.com's offering.

The global clot buster drugs market is projected to grow at a significant CAGR during the forecast period, 2023-2027. The market growth can be attributed to the rising incidences of cardiovascular diseases and the surge in demand for effective pharmaceuticals for the immediate response to heart strokes.

Clot buster drugs are heart disease drugs that aid in the dissolution of blood clots caused by vein blockage, a common cause of strokes and heart attacks. Clot buster drugs, also known as thrombolytic therapeutics, are heart medications frequently administered under medical supervision in hospitals via intravenous injection. The use of these drugs aids in the prevention of ongoing heart damage during a heart attack or deterioration due to an ischemic stroke.

In the next five years, the global clot buster drugs market is expected grow due to an increase in the prevalence of cardiovascular diseases such as heart attacks and strokes. Stroke is the fifth most common cause of death in the United States. The increasing number of strokes necessitates an immediate response to the situation, where clot buster drugs can help by dissolving the blood clot pooling in the veins, resulting in lower blood pressure.

The population's mortality rate is rising due to strokes, fueling the growth of the global clot buster drug market. Furthermore, increasing ischemic stroke risks in the global population is expected to support the growth of the global clot buster drugs market over the next five years.

Years considered for this report:

• Historical Years: 2017-2020
• Base Year: 2021
• Estimated Year: 2022
• Forecast Period: 2023-2027

Objective of the Study:

• To analyze the historical growth in the market size of the global clot buster drugs from 2017 to 2021.
• To estimate and forecast the market size of global clot buster drugs market from 2023 to 2027 and growth rate until 2027.
• To classify and forecast the global clot buster drugs market based on type, application, distribution channel, region, and company.
• To identify the dominant region or segment in the global clot buster drugs market.
• To identify drivers and challenges for the global clot buster drugs market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the global clot buster drugs market.
• To identify and analyze the profiles of leading players operating in the global clot buster drugs market.
• To identify key sustainable strategies adopted by market players in global clot buster drugs market.

Companies Mentioned

• F. Hoffmann-La Roche AG
• Taj Pharmaceuticals Limited
• Eumedica Pharmaceuticals SA
• SEDICO Pharmaceutical Company
• Mochida Pharmaceutical Co., Ltd
• Medac GmbH
• Microbix Biosystems Inc
• Crinos S.p.A.

Report Scope:

In this report, global clot buster drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Clot Buster Drugs Market, By Type:

• Fibrin Specific Drugs
• Tissue Plasminogen Activator
• Reteplase
• Tenecteplase
• Others
• Non-Fibrin Specific Drugs
• Urokinase
• Streptokinase
• Plasminogen Activating Complex

Clot Buster Drugs Market, By Application:

• Myocardial Infarction
• Pulmonary Embolism
• Deep Vein Thrombosis
• Acute Ischemic Strokes
• Others

Clot Buster Drugs Market, By Distribution Channel:

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

Clot Buster Drugs Market, By Region:

• North America
• United States
• Mexico
• Canada
• Europe
• France
• Germany
• United Kingdom
• Italy
• Spain
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Australia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Egypt
• South America
• Brazil
• Argentina
• Colombia

For more information about this report visit https://www.researchandmarkets.com/r/pnn4f8

View source version on businesswire.com:https://www.businesswire.com/news/home/20220926005516/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2022.